大行評級|高盛:上調攜程目標價至588港元 季績穩健並再次超出預期
高盛發表研究報吿指,攜程第三季業績穩健並再次超出預期。其中盈利按年上升22%至60億元,超出市場預期的50億元,與上季相比,繼續由較好的利潤率帶動,營銷效率進一步改善。集團收入亦較該行預期高出1%,按年增長16%,處於公司指引11至16%的高位,主要是受惠於出境旅遊的強勁勢頭及Trip.com平台的增長。
高盛預計,攜程今年第四季非通用會計準則經營利潤為29億元,按年增長8%,EBIT利潤率為23.2%。該行將集團2024至26年非通用會計準則每股盈測調整0至1%,目標價由517港元調升至588港元,評級為“買入”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.